These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29969310)

  • 1. Economic and Policy Analytic Approaches to Inform the Acceleration of HIV Prevention in the United States: Future Directions for the Field.
    Martin EG; Rosenberg ES; Holtgrave DR
    AIDS Educ Prev; 2018 Jun; 30(3):199-207. PubMed ID: 29969310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A benefit-cost analysis of syringe exchange programs.
    Reid RJ
    J Health Soc Policy; 2000; 11(4):41-57. PubMed ID: 10620865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities.
    Quan AML; Mah C; Krebs E; Zang X; Chen S; Althoff K; Armstrong W; Behrends CN; Dombrowski JC; Enns E; Feaster DJ; Gebo KA; Goedel WC; Golden M; Marshall BDL; Mehta SH; Pandya A; Schackman BR; Strathdee SA; Sullivan P; Tookes H; Nosyk B;
    Lancet HIV; 2021 Sep; 8(9):e581-e590. PubMed ID: 34370977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa.
    Holtgrave DR; Young PA; Mayer RR; Maulsby C; Kim JJ
    AIDS Educ Prev; 2013 Oct; 25(5):423-9. PubMed ID: 24059879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for allocating CDC's HIV prevention resources in the United States.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunity costs and uncertainty in the economic evaluation of health care interventions.
    Sendi P; Gafni A; Birch S
    Health Econ; 2002 Jan; 11(1):23-31. PubMed ID: 11788979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: a closing window for success?
    Holtgrave DR; Hall HI; Wehrmeyer L; Maulsby C
    AIDS Behav; 2012 Aug; 16(6):1365-72. PubMed ID: 22610372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What about Us? Economic and Policy Changes Affecting Rural HIV/AIDS Services and Care.
    Albritton T; Martinez I; Gibson C; Angley M; Grandelski VR
    Soc Work Public Health; 2017; 32(4):273-289. PubMed ID: 28276893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS.
    Ryan GW; Bloom EW; Lowsky DJ; Linthicum MT; Juday T; Rosenblatt L; Kulkarni S; Goldman DP; Sayles JN
    Health Aff (Millwood); 2014 Mar; 33(3):410-7. PubMed ID: 24590938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions.
    Anderson SJ; Ghys PD; Ombam R; Hallett TB
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29220115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What works, and what remains to be done, in HIV prevention in the United States.
    Holtgrave DR; Curran JW
    Annu Rev Public Health; 2006; 27():261-75. PubMed ID: 16533117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing HIV in U.S. women and girls: a call for social action.
    Gómez CA
    Womens Health Issues; 2011 Nov; 21(6 Suppl):S287-94. PubMed ID: 22055680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.
    Rowley JT; Anderson RM; Ng TW
    AIDS; 1990 Jan; 4(1):47-56. PubMed ID: 2317308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aligning budget with U.S. National HIV prevention priorities.
    Valdiserri RO; Ogden LO; Janssen RS; Onorato I; Martin T
    J Public Health Manag Pract; 2004; 10(2):140-7. PubMed ID: 14967981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of HIV counseling-and-testing services: making the most of limited resources.
    Holtgrave DR; Reiser WJ; Di Franceisco W
    AIDS Educ Prev; 1997 Jun; 9(3 Suppl):105-18. PubMed ID: 9241402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Impact of the Affordable Care Act on HIV Care, Outcomes, Prevention, and Disparities: A Critical Research Agenda.
    Lipira L; Williams EC; Hutcheson R; Katz AB
    J Health Care Poor Underserved; 2017; 28(4):1254-1275. PubMed ID: 29176093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.
    Over M; Marseille E; Sudhakar K; Gold J; Gupta I; Indrayan A; Hira S; Nagelkerke N; Rao AS; Heywood P
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S145-52. PubMed ID: 17003679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontloading HIV financing maximizes the achievable impact of HIV prevention.
    Anderson SJ; Ghys PD; Ombam R; Hallett TB
    J Int AIDS Soc; 2018 Mar; 21(3):e25087. PubMed ID: 29498234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Recent HIV Prevention Interventions and Future Considerations for Nursing Science.
    Threats M; Brawner BM; Montgomery TM; Abrams J; Jemmott LS; Crouch PC; Freeborn K; Kamitani E; Enah C
    J Assoc Nurses AIDS Care; 2021 May-Jun 01; 32(3):373-391. PubMed ID: 33929980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health. Global HIV/AIDS policy in transition.
    Bongaarts J; Over M
    Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.